loadpatents
name:-0.020303010940552
name:-0.016273021697998
name:-0.00090885162353516
WILD; Hanno Patent Filings

WILD; Hanno

Patent Applications and Registrations

Patent applications and USPTO patent grants for WILD; Hanno.The latest application filed is for "substituted dihydropyrazolones for treating cardiovascular and hematological diseases".

Company Profile
0.19.15
  • WILD; Hanno - Wuppertal DE
  • Wild; Hanno - Orange CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases
App 20160229858 - THEDE; Kai ;   et al.
2016-08-11
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
Grant 9,168,249 - Thede , et al. October 27, 2
2015-10-27
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
Grant 9,085,572 - Flamme , et al. July 21, 2
2015-07-21
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases
App 20150148381 - THEDE; Kai ;   et al.
2015-05-28
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
Grant 8,987,261 - Thede , et al. March 24, 2
2015-03-24
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
Grant 8,653,111 - Thede , et al. February 18, 2
2014-02-18
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases
App 20140031329 - THEDE; Kai ;   et al.
2014-01-30
Substituted dipyridyl-dihydropyrazolones and use thereof
Grant 8,609,698 - Thede , et al. December 17, 2
2013-12-17
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
Grant 8,524,699 - Thede , et al. September 3, 2
2013-09-03
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
Grant 8,389,520 - Thede , et al. March 5, 2
2013-03-05
Substituted Imidazopyrimidines And Triazolopyrimidines
App 20120322772 - FLAMME; Ingo ;   et al.
2012-12-20
Substituted Dihydropyrazolones And Use Thereof As Hif-prolyl-4 -hydroxylase Inhibitors
App 20120264704 - Thede; Kai ;   et al.
2012-10-18
Dipyridyl-dihydropyrazolones and their use
Grant 8,252,817 - Flamme , et al. August 28, 2
2012-08-28
Raf Kinase Inhibitors
App 20120178780 - WOOD; Jill E. ;   et al.
2012-07-12
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases
App 20120121727 - THEDE; Kai ;   et al.
2012-05-17
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases
App 20100305085 - Thede; Kai ;   et al.
2010-12-02
Substituted Dipyridyl-dihydropyrazolones And Use Thereof
App 20100093803 - Thede; Kai ;   et al.
2010-04-15
Raf Kinase Inhibitors
App 20100063088 - WOOD; Jill E. ;   et al.
2010-03-11
Dipyridyl-dihydropyrazolones and their use
App 20100035906 - Flamme; Ingo ;   et al.
2010-02-11
Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
App 20060183753 - Erguden; Jens ;   et al.
2006-08-17
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases
Grant 7,045,544 - Erguden , et al. May 16, 2
2006-05-16
Raf kinase inhibitors
App 20050256174 - Wood, Jill E. ;   et al.
2005-11-17
Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
App 20050038101 - Erguden, Jens-Kerim ;   et al.
2005-02-17
Raf kinase inhibitors
App 20010006975 - Wood, Jill E. ;   et al.
2001-07-05
Inhibition of raf kinase activity using aryl ureas
Grant 6,187,799 - Wood , et al. February 13, 2
2001-02-13
Heteroatom-containing cyclopentanopyridyl-oxazolidinones
Grant 5,869,659 - Stolle , et al. February 9, 1
1999-02-09
Benzofuranyl -and benzothienyloxazolidinones
Grant 5,684,023 - Riedl , et al. November 4, 1
1997-11-04
6-membered nitrogen-containing heteroaryl-oxazolidinones
Grant 5,627,181 - Riedl , et al. May 6, 1
1997-05-06
Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation
Grant 5,492,918 - Wild , et al. February 20, 1
1996-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed